Kytopen Posts

Author: Kytopen

Spun out of an MIT lab, sitting in an office space above a Cambridge tapas restaurant from...
One of the tricks of getting cell therapies to work is getting the payload you want into the cell...
In the laboratory, induced pluripotent stem (iPS) cells can seem like magic: derived from...
Financing will accelerate momentum toward unlocking the linearity between discovery and...
NIH/NIAID SBIR Fast Track grant accelerates the company’s commercial activities towards a non-viral...
The 2021 Cellicon Valley Symposium is presented by Penn’s Abramson Cancer Center and Children’s...
What if a cancer patient could receive life-saving cellular therapy within days of diagnosis rather...
2021 Cell & Gene Meeting on the Med organized by the Alliance for Regenerative Medicine, was held...
Greg Crescenzi Joins Kytopen as Chief Commercial Officer to Drive Discovery, Development and...
BioCentriq™, the New Jersey Innovation Institute’s cell and gene therapy development and...